Zobrazeno 1 - 10
of 43
pro vyhledávání: '"Mittie K. Doyle"'
Autor:
Mark N. Polizzotto, Jacqueline Nordwall, Abdel G. Babiker, Andrew Phillips, David M. Vock, Nnakelu Eriobu, Vivian Kwaghe, Roger Paredes, Lourdes Mateu, Srikanth Ramachandruni, Rajeev Narang, Mamta K. Jain, Susana M. Lazarte, Jason V. Baker, Anne E.P. Frosch, Garyfallia Poulakou, Konstantinos N. Syrigos, Gretchen S. Arnoczy, Natalie A. McBride, Philip A. Robinson, Farjad Sarafian, Sanjay Bhagani, Hassan S. Taha, Thomas Benfield, Sean T.H. Liu, Anastasia Antoniadou, Jens Ulrik Stæhr Jensen, Ioannis Kalomenidis, Adityo Susilo, Prasetyo Hariadi, Tomas O. Jensen MD, Jose Luis Morales-Rull, Marie Helleberg, Sreenath Meegada, Isik S. Johansen, Daniel Canario, Eduardo Fernández-Cruz, Simeon Metallidis, Amish Shah, Aki Sakurai, Nikolaos G. Koulouris, Robin Trotman, Amy C. Weintrob, Daria Podlekareva, Usman Hadi, Kathryn M. Lloyd, Birgit Thorup Røge, Sho Saito, Kelly Sweerus, Jakob J. Malin, Christoph Lübbert, Jose Muñoz, Matthew J. Cummings, Marcelo H. Losso, Dan Turner, Kathryn Shaw-Saliba, Robin Dewar, Helene Highbarger, Perrine Lallemand, Tauseef Rehman, Norman Gerry, Dona Arlinda, Christina C. Chang, Birgit Grund, Michael R. Holbrook, Horace P. Holley, Fleur Hudson, Laura A. McNay, Daniel D. Murray, Sarah L. Pett, Megan Shaughnessy, Mary C. Smolskis, Giota Touloumi, Mary E. Wright, Mittie K. Doyle, Sharon Popik, Christine Hall, Roshan Ramanathan, Huyen Cao, Elsa Mondou, Todd Willis, Joseph V. Thakuria, Leman Yel, Elizabeth Higgs, Virginia L. Kan, Jens D. Lundgren, James D. Neaton, H. Clifford Lane
Publikováno v:
Lancet (London, England)
Background Passive immunotherapy using hyperimmune intravenous immunoglobulin (hIVIG) to SARS-CoV-2, derived from recovered donors, is a potential rapidly available, specific therapy for an outbreak infection such as SARS-CoV-2. Findings from randomi
Autor:
Dean Juge, Kushang V. Patel, Tina Tockarshewsky, Eric Devine, Lee S. Simon, John T. Farrar, Geertrui F. Vanhove, Michael P. McDermott, Michael C. Rowbotham, Richard Rauck, Dennis C. Turk, James N. Campbell, Ajay D. Wasan, Philip G. Conaghan, G. Niebler, Mark P. Jensen, Bernard Vrijens, Mittie K. Doyle, David J. Hewitt, Jennifer S. Gewandter, Neil Singla, Daniel B. Carr, Ernest A. Kopecky, Vladimir Skljarevski, Andrew S.C. Rice, Scott R. Evans, Robert D. Kerns, James Witter, Amy A. Kirkwood, Roy Freeman, Richard Malamut, Ian Gilron, Robert H. Dworkin, Nathaniel P. Katz, Penney Cowan, Robert R. Edwards, Nelson E. Sessler, Laurie B. Burke, John D. Markman
Publikováno v:
J Pain
The estimated probability of progressing from phase 3 analgesic clinical trials to regulatory approval is approximately 57%, suggesting that a considerable number of treatments with phase 2 trial results deemed sufficiently successful to progress to
Autor:
Christopher, Ritchlin, Proton, Rahman, Arthur, Kavanaugh, Iain B, McInnes, Lluis, Puig, Shu, Li, Yuhua, Wang, Yaung-Kaung, Shen, Mittie K, Doyle, Alan M, Mendelsohn, Alice B, Gottlieb, A, Zubrzycka
Publikováno v:
Annals of the Rheumatic Diseases
ANNALS OF THE RHEUMATIC DISEASES
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
ANNALS OF THE RHEUMATIC DISEASES
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
Objective Assess ustekinumab efficacy (week 24/week 52) and safety (week 16/week 24/week 60) in patients with active psoriatic arthritis (PsA) despite treatment with conventional and/or biological anti-tumour necrosis factor (TNF) agents. Methods In
Autor:
Mittie K. Doyle, Stephen Xu, Bernardo A. Pons-Estel, Paul Emery, Peter Nash, Patrick Durez, Zhong Wu, Roy Fleischmann, Ingrid Strusberg, W. Xu, Eric Amante, Won Park, Melvin Churchill, Elizabeth C. Hsia
Publikováno v:
Arthritis Care & Research. 65:1732-1742
To assess 2-year golimumab efficacy/safety in patients with active rheumatoid arthritis (RA) who had never taken methotrexate (MTX).RA patients who had never taken MTX (n = 637) were randomized (1:1:1:1) to placebo + MTX (group 1), golimumab 100 mg +
Autor:
Mittie K. Doyle, Jonathan Kay, Eric L. Matteson, Stephen Xu, Josef S Smolen, Yiying Zhou, Robert Landewé, Elizabeth C. Hsia
Publikováno v:
Annals of the Rheumatic Diseases
Annals of the rheumatic diseases, 73(10), 1811-1818. BMJ Publishing Group
Annals of the rheumatic diseases, 73(10), 1811-1818. BMJ Publishing Group
Objective Evaluate golimumab in patients with active rheumatoid arthritis (RA) and previous tumour necrosis factor-α (TNF) inhibitor use. Methods Patients (n=461) previously receiving ≥1 TNF inhibitor were randomised to subcutaneous injections of
Autor:
A. Beutler, Elizabeth C. Hsia, Stephen Xu, Mittie K. Doyle, Mahboob Rahman, Benjamin Hsu, Richard E. Chaisson, John J. Cush, Eric L. Matteson, Neil W. Schluger
Publikováno v:
Arthritis & Rheumatism. 64:2068-2077
Objective To evaluate the performance of an interferon-γ release assay (IGRA) versus the standard tuberculin skin test (TST) as a screening tool for latent tuberculosis (TB) infection prior to the initiation of anti–tumor necrosis factor therapy i
Autor:
Norman Gaylis, Jürgen Wollenhaupt, Yiying Zhou, Elizabeth C. Hsia, Josef S Smolen, Robert Landewé, Jonathan Kay, Mittie K. Doyle, Eric L. Matteson, Frederick T. Murphy
Publikováno v:
Annals of the Rheumatic Diseases
Annals of the rheumatic diseases, 71(10), 1671-1679. BMJ Publishing Group
Annals of the rheumatic diseases, 71(10), 1671-1679. BMJ Publishing Group
Objective The aim of this study was to assess long-term golimumab therapy in patients with rheumatoid arthritis (RA) who discontinued previous tumour necrosis factor alpha (TNFα) inhibitor(s) for any reason. Methods Results through week 24 of this m
Autor:
Adele Morganti, Christopher P. Denton, Marco Matucci-Cerinic, Fabrice Kramer, Nadera J. Sweiss, Carol M. Black, Bernhard Hellmich, Thomas A. Medsger, Barri J. Fessler, Vivien Hsu, Maureen D. Mayes, Joseph H. Korn, James R. Seibold, Patrick H. Carpentier, Peter A. Merkel, Mittie K. Doyle, Daniel E. Furst, Janet E. Pope, Fredrick M. Wigley
Publikováno v:
Annals of the Rheumatic Diseases
Objectives Ischaemic digital ulcers (DUs) are common in patients with systemic sclerosis (SSc) and are a cause of disease-related morbidity. In an earlier trial, treatment with bosentan, an oral endothelin receptor antagonist, reduced the occurrence
Publikováno v:
Current Medical Research and Opinion. 26:2157-2163
Studies suggest that serum uric acid (SUA) is significantly associated with cardiovascular disease (CVD) mortality among women and blacks. CVD rates are higher among patients with rheumatoid arthritis (RA) than the normal population. The objective of
Autor:
Joan M. Bathon, Jon T. Giles, Clifton O. Bingham, Chenglong Han, Mahboob Rahman, Mittie K. Doyle, J. Han
Publikováno v:
Seminars in Arthritis and Rheumatism. 39:123-131
To evaluate the effect of antitumor necrosis factor-alpha monoclonal antibody infliximab treatment on anemia in patients with rheumatoid arthritis (RA).Data from patients with RA who received infliximab or placebo in the multicenter, placebo-controll